Access personalized CAR-T care using advanced medical technology, supported by expert specialists and dedicated international patient services.
Amrita Hospital uses advanced cellular manufacturing techniques and immunotherapy protocols to provide CAR T-cell therapy services. Founded in 2022, this institution is based in Faridabad, India, and has 2600 beds, with NABH recognition, to assist both local and foreign patients.
The CAR-T process is beneficial for some patients with blood cancers that have failed prior treatment and returned, depending on the disease type and the approved indication. In CAR-T therapy, T cells are collected, engineered to recognise cancer cells, multiplied, and then infused back after proper preparation of the cells. The cancer treatment team performs a careful assessment of the disease and health history before individualisation of treatment.